ASSYSTEM_Registration_Document_2017

FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL STATEMENTS

LIABILITIES RELATED TO SHARE ACQUISITIONS (CURRENT AND NON-CURRENT) AND OTHER NON-CURRENT LIABILITIES

NOTE 10

In some cases the Group grants put options to minority shareholders of its subsidiaries in relation to their non-controlling interests held in those subsidiaries. The exercise price of these options may be fixed or based on a pre-determined formula. Where such put options are granted, the Group recognises a related financial liability. This liability is initially recognised at the present value of the exercise price and at the end of subsequent reporting periods it is measured by reference to the fair value of the shares that would potentially have to be purchased if the exercise price is based on fair value. Subsequent changes in the fair value of the put options are recognised in financial income or expenses. The Group also recognises a non-current liability for the discounted amounts relating to commitments to pay dividends to third-party shareholders. The amount recorded in the consolidated financial statements at 31 December 2017 for put options granted to non-controlling interests totalled €9.1 million, all of which was recognised in non-current liabilities related to share acquisitions (€18.5 million at 31 December 2016). The amounts recognised as liabilities for put options chiefly relate to the following acquisitions: ● Biotech Quality Group – €4.1 million (see Note 3.2 – Business combinations). The discounted amounts relating to commitments to pay dividends to third-party shareholders are recorded under “Other non-current liabilities”. They totalled €1.8 million at 31 December 2017 and concerned Envy. Movements in liabilities related to the non-controlling interests in Envy are described in Note 8.5 – Financial income and expenses. ● Envy – €5.0 million;

ADDITIONAL INFORMATION ON FINANCIAL ASSETS AND LIABILITIES

NOTE 11

11.1 Accounting classification of financial assets and liabilities

FINANCIAL ASSETS The table below shows the carrying amounts and fair values of the Group’s financial assets over the past two years:

6

2017

2016

Financial assets at fair value through profit or loss

Available-for- sale financial assets

Financial assets at amortised cost

Carrying amount

Carrying amount

Derivatives

Fair value

In millions of euros Investment property

1.4

-

-

1.4

-

1.4

1.4

Assystem Technologies Groupe convertible bonds

63.6

-

63.6

- - - - - -

- - - -

63.6

-

Other financial assets Trade receivables Other receivables* Other current assets

128.6 160.0

124.4

4.2

128.6 160.0

13.9

- - - -

160.0

320.1

5.7 0.5

5.7 0.2

5.7 0.5

4.9 0.3

0.3

Cash and cash equivalents

28.2

28.2

-

28.2

85.4

Total

388.0

124.4

261.9

1.4

0.3

388.0

426.0

* Excluding employee-related receivables, tax receivables and prepaid expenses.

131

ASSYSTEM

REGISTRATION DOCUMENT 2017